P.2.a.015 Addition of atomoxetine for depression incompletely responsive to sertraline: a randomized, double-blind, placebo-controlled study by Michelson, D., Adler, L.A., Amsterdam, J.D., Dunner, D.L., Nierenberg, A.A., Reimherr, F.W., Schatzberg, A.F., Kelsey, D.K., Feldman, P.D., Levine, L.R., Williams, D.W.

Get full text

P.6.024 Quality-of-life assessment in atomoxetine-treatedadult patients with attention-deficit/hyperactivity disorder by Adler, L., Kelsey, D.K., Dietrich, A., Reimherr, F., Sandal, R.B., Saylor, K., Secnik, K., Sutton, V., Moore, R.

Get full text

P.6.039 Atomoxetine treatment in children with attention-deficit/hyperactivity disorder and comorbid tic disorders by Allen, A.J., Kurlan, R.M., Linder, S.L., Lewis, D.W., Winner, P.K., Gilbert, D.L., Dunn, D.W., Sallee, F.R., Milton, D.R., Mintz, M.I., Ricardi, R.K., Erenberg, G., Layton, L.L., Feldman, P.D., Kelsey, D.K., Spencer, T.J.

Get full text

Safety of atomoxetine in pediatric patients treated for ADHD by Wernicke, J.F., Fouche, D.S., Spencer, T., Dunn, D., Faries, D.E., Kelsey, D.K., Heiligenstein, J.H., Michelson, D.

Get full text

Photosynthetic Declines in Phytophthora ramorum-Infected Plants Develop Prior to Water Stress and in Response to Exogenous Application of Elicitins by Manter, D.K, Kelsey, R.G, Karchesy, J.J

Get full text

sporicidal activity of yellow-cedar heartwood, essential oil and wood constituents towards Phytophthora ramorum in culture by Manter, D.K, Karchesy, J.J, Kelsey, R.G

Get full text

Effect of Swiss needle cast on Douglas-fir stem ethanol and monoterpene concentrations, oleoresin flow, and host selection by the Douglas-fir beetle by Kelsey, Rick G, Manter, Daniel K

Get full text

Carbon monoxide formation in the ductus arteriosus in the lamb: implications for the regulation of muscle tone by Coceani, F., Kelsey, L., Seidlitz, E., Marks, G.S., McLaughlin, B.E., Vreman, H.J., Stevenson, D.K., Rabinovitch, M., Ackerley, C.

Get full text

Treatment of patients with refractory, C-KIT positive, acute myeloid leukemia with SU5416, a novel receptor tyrosine kinase inhibitor by Fiedler, W., Staib, P., Kuse, R., Dührsen, U., Flasshove, M., Spataro, V., Kelsey, S., Scigalla, P., Hossfeld, D.K., Berdel, W.E.

Get full text